Newsmeme!
Discover News you didn't know existed
Diabetes Mellitus
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
ONGLYZA™ (Saxagliptin) Receives Positive Opinion In Europe For The Treatment Of Type 2 Diabetes
Published July 4, 2009, 4:11 am, Medical News Today
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that their marketing authorization application for ONGLYZA™ (saxagliptin) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of type 2 diabetes in adults as add-on therapy with metformin, a thiazolidinedione or a sulphonylurea.
London teenager becomes Britain's fourth swine flu death
Published July 3, 2009, 3:12 pm, Times Online
A 19-year-old man has become the fourth person in Britain to die after contracting swine flu and the first fatal case in London, officials announced yesterday.
In Brief This Week: Roche NimbleGen; Aushon BioSystems; Saladax Biomedical; Mobidiag; Enigma Diagnostics
Published July 3, 2009, 8:32 am, GenomeWeb News
NEW YORK (GenomeWeb News) – Roche NimbleGen said this week that it has entered into a partnership with the Korea Centers for Disease Control and sequencing services firm Macrogen to conduct an eight-month copy number variation study of Korean individuals.
Health care officials point to pain from Pawlenty budget cuts
Published July 3, 2009, 6:25 am, Brainerd Dispatch
Area health officials told state lawmakers Thursday how their institutions will be affected by the March 1 elimination of a state medical assistance program for low-income patients without private insurance.
Diabetes center expanding
Published July 2, 2009, 10:39 pm, Delaware County Times
Crozer-Keystone Health System’s Center for Diabetes is expanding to Community Hospital, 2600 W. Ninth St. in Chester.
Roche NimbleGen CNV Arrays Selected for Landmark Korean Copy Number Variation Study
Published July 2, 2009, 5:00 am, Business Wire via Yahoo! Finance
MADISON, Wis.----Roche NimbleGen has entered into a partnership with the Korea Centers for Disease Control and Prevention and Macrogen, Inc. to conduct an 8-month intensive Copy Number Variation study of Korean individuals.
Health and support
Published July 1, 2009, 10:20 pm, The Standard-Times
Cushman Park Fit Club: Sponsored by What's Up? Event Guide, 8-9 a.m. Mondays and Wednesdays through Aug. 26 in Cushman Park (weather permitting). Taught by certified fitness/functional trainer Wayne Goulart. Program includes body weight exercises,...
PPD Confirms Takeda Receives FDA Complete Response For Alogliptin
Published July 1, 2009, 9:48 pm, PharmaceuticalOnline
PPD, Inc. today announced that Takeda Pharmaceutical Company Limited issued a news release reporting that Takeda Global Research & Development Center, Inc., its wholly-owned U.S. subsidiary, has received a complete response letter from the U.S. Food and Drug Administration (FDA) regarding its new drug application (NDA) for alogliptin.
Clinical Trials Update: July 1, 2009
Published July 1, 2009, 9:45 am, Forbes
This trial is for people with chronic low back pain. Qualified participants must be at least 18, and have had low back pain for at least three months.
Clinical Trials Update: July 1, 2009
Published July 1, 2009, 9:03 am, HealthDay via Yahoo! News
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch:
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |